TB

3.

Global Fund awards $253.8 million in renewal funding

6 Jan 2014
Largest awards go to Kenya, Somalia and Viet Nam

The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has approved continued funding of up to $253.8 million for 13 applicants in a decision announced on 23 December.

3.

Renewal Funding of $46.4 Million Approved for Three Applicants

29 Nov 2013
Largest awards go to Eritrea

The Board of the Global Fund to Fights AIDS, Tuberculosis and Malaria has approved continued funding of up to $46.4 million for three applicants. The Board decision was announced on 26 November.

The Board’s approval followed recommendations from the Technical Review Panel (TRP) and the Secretariat, including the Grant Approvals Committee (GAC). See the table for a full breakdown.

7.

The Public Health Approach Makes Sense for the Global Fund

26 Nov 2013

When the Global Fund to Fight AIDS, TB and malaria was created in 2002, its aim was to provide financial support to developing countries in their battle against the three border-crossing communicable diseases for which treatment and prevention options were available.

5.

Domestic Funding For the HIV and AIDS Response

26 Nov 2013

There are just two years remaining on the clock for developing nations to achieve the Millennium Development Goals, including Goal Six, targeting the global fight against AIDS, TB and malaria.

4.

SIIC Takes Decisions on Incentive Funding and Other NFM Matters

11 Nov 2013
Funding requests in the unfunded quality demand register may stay in the register for up to three years

At its meeting on 8–9 October, the Strategy, Investment and Impact Committee (SIIC) made decisions in four areas related to the new funding model (NFM): awarding of incentive funding, managing unfunded quality demand, health systems strengthening and TB/HIV collaboration. This article provides details.

4.

First Shipment of Drugs to Treat MDR-TB in Somalia Expected to Arrive Soon, PR Says

9 Jul 2013
Somalia to start managing MDR-TB
Global Fund’s investments are channelled through World Vision

Somalia has a major burden of multi-drug-resistant TB (MDR-TB), rivalling that of the most-affected countries in Asia. According to World Vision International Somalia (WVI-S), principal recipient (PR) for the Global Fund’s TB grants in Somalia, the first shipment of medicines to treat MDR-TB is expected to arrive this month.

7.

Historic Moment Provides Many Opportunities for the Global Fund, Dybul Says

19 Jun 2013

The people involved in the Global Fund, and in global health generally, “are at an historic moment when the confluence of scientific advancement, epidemiological intelligence and experience from more than a decade of implementation come together to offer the opportunity to end three plagues as public health threats.”

3.

Funding Approved for Four More Interim Applicants

15 Jun 2013
Chad, PNG, Kenya and Mozambique will receive a total of up to $40.5 million

The Global Fund Board has approved up to $40.5 million for four interim applicant countries: Chad, Papua New Guinea (PNG), Kenya and Mozambique. The Board decisions were based on recommendations from the Grant Approvals Committee (GAC). This brings to five the number of interim applicant countries that have received funding.

4.

India Should Assume More Responsibility for Its TB Programmes, Global Fund Committee Says

4 Jun 2013
Board approves funding for next implementation period of three TB grants

Given India’s economic status, the government should assume greater responsibility for TB programmes, and should ultimately assume full responsibility.

5.

Funding for Phase 2 of TB Grant in Guinea-Bissau Approved, Despite Weak Performance in Phase 1

14 May 2013
UNDP nominated to become PR for Phase 2

Editor’s Note: Guinea-Bissau was one of seven applicants for which the Global Fund recently approved renewal funding. Articles on each of the other six renewals are available on GFO Live.

Pages

Subscribe to TB